ASX LISTED MEDICAL CANNABIS COMPANY SCORES $40 MILLION COSMETICS AGREEMENT
GC PHARMA (ASX: MXC) has finalised a deal with Korean cosmetics manufacturer Varm Cosmo worth $40 million.
The deal is set to deliver significant revenues for MGC, expected to be in excess of $3 million of sales per month.
The company has executed a binding terms and conditions agreement for a white-label cannabidiol (CBD) cosmetics product with Korean manufacturer Vram Cosmo.
https://www.businessnewsaus.com.au/...ompany-scores--40-million-cosmetics-agreement
$40 MILLION, page-12
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
